Gilead Sciences (GILD) Inventory Average (2009 - 2026)

Gilead Sciences (GILD) has reported Inventory Average for 18 consecutive years, with $1.9 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Inventory Average rose 7.9% year-over-year to $1.9 billion; the trailing twelve-month figure through Jun 2026 stood at $1.9 billion (up 7.9% YoY), and the FY2025 full-year result was $1.7 billion, changed 0.37% from the prior year.
• Inventory Average climbed to $1.9 billion in Q2 2026 per GILD's latest filing, from $1.8 billion in the prior quarter.
• Across five years, Inventory Average topped out at $1.9 billion in Q3 2024 and bottomed at $1.5 billion in Q3 2022.
• Historically, Inventory Average has averaged $1.7 billion across 5 years, with a median of $1.8 billion in 2025.
• The sharpest annual moves came in 2022 and 2024: Inventory Average declined 16.19% in 2022, then increased 20.88% in 2024.
• Over 5 years, Inventory Average stood at $1.5 billion in 2022, then gained by 16.16% to $1.7 billion in 2023, then rose by 3.74% to $1.8 billion in 2024, then decreased by 0.56% to $1.8 billion in 2025, then grew by 8.65% to $1.9 billion in 2026.
• According to Business Quant data, Inventory Average over the past three periods registered $1.9 billion, $1.8 billion, and $1.8 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.